Cited by 47Macrophage Migration Inhibitory FactorInterstitial Lung Diseases and Idiopathic Pulmonary FibrosisChronic Obstructive Pulmonary Disease (COPD) Research

The role of MIF in chronic lung diseases: looking beyond inflammation

Open access
Florez-Sampedro, Laura, Soto-Gamez, Abel, Poelarends, Gerrit J., Melgert, Barbro N.·2020·American Journal of Physiology-Lung Cellular and Molecular Physiology

Abstract

Macrophage migration inhibitory factor (MIF) is a pleiotropic cytokine that has been associated with many diseases. Most studies found in literature describe MIF as a proinflammatory cytokine involved in chronic inflammatory conditions, but evidence from last years suggests that many of its key effects are not directly related to inflammation. In fact, MIF is constitutively expressed in most human tissues and in some cases in high levels, which does not reflect the pattern of expression of a classic proinflammatory cytokine. Moreover, MIF is highly expressed during embryonic development and decreases during adulthood, which point toward a more likely role as growth factor. Accordingly, MIF knockout mice develop age-related spontaneous emphysema, suggesting that MIF presence (e.g., in younger individuals and wild-type animals) is part of a healthy lung. In view of this new line of evidence, we aimed to review data on the role of MIF in the pathogenesis of chronic lung diseases.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1152/ajplung.00521.2019

Cites

108 of 108 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • MIF appears to be pivotal for cellular senescence, aging, and joint inflammation; however, its presence has been associated with a beneficial effect on the healthy lung and in MSCs.

    “MIF appears to be pivotal for cellular senescence, aging, and joint inflammation; however, its presence has been associated with a beneficial effect on the healthy lung and in MSCs73–78.”

    From A new gene set identifies senescent cells and predicts senescence-associated pathways across tissues (2022) · cites this paper as [76]

    The review links MIF to aging and cellular senescence and says it may protect the lung from senescence and damage (MIF IN CHRONIC LUNG DISEASES, p. 3). Its table also lists a protective effect in mesenchymal stem cells (CHRONIC LUNG DISEASES AND MIF, p. 5). The passages do not establish the claim about joint inflammation. (LLM, conf=0.85)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Florez-Sampedro, L., Soto-Gamez, A., Poelarends, G. J., & Melgert, B. N.
Affiliations
  • Department of Chemical and Pharmaceutical Biology, Groningen Research Institute of Pharmacy, University of Groningen, Groningen, The Netherlands
  • University Medical Center Groningen (NL)
  • University of Groningen (NL)
Corresponding author
Melgert, Barbro N.
Venue
American Journal of Physiology-Lung Cellular and Molecular Physiology
Published
2020-06-01
Volume
318
Issue
6
Pages
L1183-L1197
ISSN
  • 1040-0605 (ISSN-L)
  • 1522-1504
OpenAlex
W3013790306
Cited by
47
References
108
Citations by year
2026: 4 · 2025: 8 · 2024: 8 · 2023: 7 · 2022: 8 · 2021: 10 · 2020: 2
FWCI
0.66
Type
journal article
Language
en
Open access
Locations
  • American Journal of Physiology-Lung Cellular and Molecular Physiology (publishedVersion)
  • PubMed (publishedVersion)
  • University of Groningen research database (University of Groningen / Centre for Information Technology) (publishedVersion, other-oa)
  • University of Groningen research database (University of Groningen / Centre for Information Technology) (submittedVersion, other-oa)
Topics
  • Life Sciences › Immunology and Microbiology › Immunology › Macrophage Migration Inhibitory Factor
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Chronic Obstructive Pulmonary Disease (COPD) Research
Keywords
macrophage migration inhibitory factor, chronic lung disease, MIF knockout mice, spontaneous emphysema, growth factors, embryonic development, lung development, inflammation
MeSH terms
Animals, Chronic Disease, Humans, Inflammation, Lung Diseases, Macrophage Migration-Inhibitory Factors

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review